HeartSciences CEO to Participate in the Benzinga All Access Event on July 15th

"Skip to content\nHome\nProducts\nClinical\nNews\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHeartSciences CEO to Participate in the Benzinga All Access Event on July 15th\nJuly 13, 2022\n\nSouthlake, Texas, July 13, 2022 (GLOBE NEWSWIRE) — HeartSciences (NASDAQ: HSCS; HSCSW) (“Company”), a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to significantly expand and improve an ECG’s clinical usefulness, today announced that Andrew Simpson, CEO, and Chairman of HeartSciences, will be participating in the Benzinga All Access event taking place on July 15, 2022.\n\nMr. Simpson is scheduled to present on Friday, July 15, 2022, at 10:00 A.M. Eastern Time.\n\nThe event will be broadcast live and can be viewed https://www.youtube.com/watch?v=JuM_q3iRTeM&feature=youtu.be. An archived recording of the presentation will be available on the investor relations section of the Company’s website at https://ir.heartsciences.com/.\n\nContacts\nMEDIA RELATIONS\n\nGene Gephart\nDirector of Marketing\n+1-682-244-2578 (US)\n\ngene.gephart@heartsciences.com\nINVESTOR CONTACT\n\nMark Komonoski – Partner\nIntegrous Communications\nDirect: 877-255-8483\n\ninvestorrelations@heartsciences.com\nwww.integcom.us\n